Palisade Bio (PALI) Cash & Equivalents (2010 - 2026)
Palisade Bio (PALI) reported Cash & Equivalents of $129.6 million for Q1 2026, up 1692.12% year-over-year from $7.2 million in Q1 2025, and down 2.14% on a QoQ basis from $132.4 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Cash & Equivalents data on file, last reported at $129.6 million in Q1 2026.
- Quarterly Cash & Equivalents rose 1692.12% year-over-year to $129.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $129.6 million (up 1692.12% YoY) and the FY2025 annual result came in at $132.4 million, up 1256.13% from the prior year.
- Cash & Equivalents slipped to $129.6 million in Q1 2026 per PALI's latest filing, from $132.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $132.4 million in Q4 2025 and bottomed at $5.0 million in Q2 2022.
- The 5-year median for Cash & Equivalents is $11.4 million (2024), against an average of $24.5 million.
- The widest annual swing landed in 2022, when Cash & Equivalents plunged 60.64%; it then surged 1692.12% in 2026.
- Tracing PALI's Cash & Equivalents over 5 years: stood at $12.4 million in 2022, then increased by 0.4% to $12.4 million in 2023, then retreated by 21.47% to $9.8 million in 2024, then surged by 1256.13% to $132.4 million in 2025, then fell by 2.14% to $129.6 million in 2026.
- Per Business Quant, the three latest PALI Cash & Equivalents figures stand at $129.6 million (Q1 2026), $132.4 million (Q4 2025), and $5.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 129.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.57 Mn |
| Dec 31, 2025 | 132.40 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 9.76 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 11.35 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 12.43 Mn |
| Sep 30, 2023 | 15.31 Mn |
| Jun 30, 2023 | 16.40 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 12.38 Mn |
| Sep 30, 2022 | 13.99 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Sep 30, 2021 | 14.10 Mn |
| Jun 30, 2021 | 12.65 Mn |
| Mar 31, 2021 | 615,000.00 |
| Dec 31, 2020 | 713,000.00 |
| Sep 30, 2020 | 751,000.00 |
| Jun 30, 2020 | 1.52 Mn |
| Mar 31, 2020 | 10.03 Mn |
| Dec 31, 2019 | 5.11 Mn |
| Sep 30, 2019 | 7.30 Mn |
| Jun 30, 2019 | 2.28 Mn |
| Mar 31, 2019 | 4.01 Mn |
| Dec 31, 2018 | 5.79 Mn |
| Sep 30, 2018 | 5.74 Mn |
| Jun 30, 2018 | 7.09 Mn |
| Mar 31, 2018 | 9.72 Mn |
| Dec 31, 2017 | 6.67 Mn |
| Sep 30, 2017 | 9.06 Mn |
| Jun 30, 2017 | 6.44 Mn |
| Mar 31, 2017 | 11.68 Mn |
| Dec 31, 2016 | 15.19 Mn |
| Sep 30, 2016 | 5.68 Mn |
| Jun 30, 2016 | 11.13 Mn |
| Mar 31, 2016 | 7.62 Mn |
| Dec 31, 2015 | 4.72 Mn |
| Sep 30, 2015 | 13.13 Mn |
| Jun 30, 2015 | 8.65 Mn |
| Mar 31, 2015 | 13.59 Mn |
| Dec 31, 2014 | 12.52 Mn |
| Sep 30, 2014 | 11.95 Mn |
| Jun 30, 2014 | 15.23 Mn |
| Mar 31, 2014 | 18.34 Mn |
| Dec 31, 2013 | 16.85 Mn |
| Sep 30, 2013 | 16.40 Mn |
| Jun 30, 2013 | 11.17 Mn |
| Mar 31, 2013 | 12.66 Mn |
| Dec 31, 2012 | 7.44 Mn |
| Sep 30, 2012 | 9.87 Mn |
| Jun 30, 2012 | 2.54 Mn |
| Mar 31, 2012 | 5.14 Mn |
| Dec 31, 2011 | 2.35 Mn |
| Sep 30, 2011 | 4.20 Mn |
| Jun 30, 2011 | 6.14 Mn |
| Mar 31, 2011 | 8.55 Mn |
| Dec 31, 2010 | 9.26 Mn |
| Sep 30, 2010 | 11.59 Mn |
| Jun 30, 2010 | 14.03 Mn |